Westcove

2025 in Review

Building on Westcove Partners’ continued momentum, we are pleased to share our 2025 firmwide update.

Summary

Westcove continued to build momentum in 2025, driven by the trust of our clients, industry partners, and investors. During 2025, our team advised founder-led businesses across clinical research, specialty pharmacy, behavioral health, plastic and reconstructive surgery, cardiology, and dental services, while deepening our presence as a healthcare-focused boutique investment bank. The firm was recognized as Healthcare Boutique Investment Bank of the Year for 2024 by the M&A Atlas Awards, nominated again for the 2025 award, and named a Top 50 Middle Market Investment Bank by Grady Campbell. At the same time, Westcove expanded its impact initiatives through the Westcove Partners Endowment and continued to grow its internship and co-op programs, reflecting our commitment to supporting the next generation of healthcare leaders and entrepreneurs.

2025 Transaction Overview

Completed Transactions Overview

Below, are brief overviews of the closed transactions in 2025:

The Prescription Center Partners with Altruix (a portfolio company of Windrose Health Investors)

Based in Scranton, Pennsylvania, The Prescription Center (“TPC”) operates both a specialty pharmacy focused on behavioral health and a retail pharmacy, serving more than 6,700 patients and filling over 170,000 prescriptions annually across Northeastern Pennsylvania. The transaction aligns a highly regarded independent pharmacy with a scaled behavioral health pharmacy platform to expand access and enhance continuity of care for complex patient populations.

“Westcove treated this process with the same care and urgency that we’ve dedicated to our patients. Their team was accessible and relentless from start to finish, guiding us through each step and making a complex process feel manageable.”

– Michael Ruane II, Owner of The Prescription Center

Coastal Research Institute Partners with Rovia Clinical Research (a portfolio company of Gauge Capital)

Coastal Research Institute (“CRI”) is a physician-led clinical research site in Fayetteville, North Carolina, with more than two decades of experience across metabolic and liver disease trials, including MASH/MASLD, gastroenterology, and weight-loss indications, having conducted over 200 studies and enrolled more than 10,000 patients. Partnering with Rovia creates a scaled platform focused on high-quality Phase II–IV clinical research, expanding patient access while preserving CRI’s patient-first culture.

“What makes Westcove superior is their commitment to understanding the company and its goals before navigating the field for a potential partner. Throughout the entire process, their team remained ‘on call’ for Coastal Research in a full pledge to ensure that the transaction felt like an enhancement to what we are already doing. Their expertise and dedication to success stood as the driving force behind the powerhouse that is Westcove.”

– John Poulos, M.D., Owner of Coastal Research Institute

NYBRA Plastic Surgery Partners with ARSA (backed by Webster Equity Partners)

NYBRA Plastic Surgery (“NYBRA”) is a leading reconstructive and cosmetic plastic surgery practice headquartered in Great Neck, New York, with additional locations in Manhattan, Commack, and Huntington, performing approximately 600 DIEP flap procedures annually. The surgeons at NYBRA are recognized thought leaders in microsurgical breast reconstruction, and this partnership is designed to support continued growth while preserving the group’s physician-led culture and patient-centered approach.

“For physicians with limited knowledge in this space, Westcove provided us with detailed education and unparalleled availability to allow us to stay focused on our clinical practice during a comprehensive process.”

– Randall Feingold, M.D., Founding Partner at NYBRA Plastic Surgery

Cardiology Consultants of Philadelphia Partners with Cardiovascular Logistics (a portfolio company of Lee Equity)

Cardiology Consultants of Philadelphia (“CCP”) is a leading cardiology practice with more than 30 offices and over 100 physicians serving patients across the greater Philadelphia region. The partnership supports CCP’s next phase of growth and advances its mission of delivering high-quality cardiovascular care at scale while navigating an increasingly complex healthcare landscape.

“Westcove was an exceptional partner throughout the process. Their deep healthcare expertise, thoughtful approach, and alignment with our goals were instrumental in achieving an outcome we are proud of.”

– Dr. Mark Victor, CEO of Cardiology Consultants of Philadelphia

Regional Plastic Surgery Center & Spa Partners with ARSA (a portfolio company of Webster Equity Partners)

Founded in 1991 and operating out of Richardson and Rockwall, Texas, Regional Plastic Surgery Center & Spa (“RPSC”) provides a full spectrum of cosmetic and reconstructive procedures through a team of seven providers, including board-certified surgeons and mid-level clinicians, serving more than 4,100 patients annually. The transaction positions RPSC to expand its footprint and capabilities while maintaining the practice’s focus on personalized, high-quality patient care.

“Joining forces with ARSA allows us to strengthen our practice and enhance our services. The alignment of our values and vision made this a natural fit. We are incredibly grateful for Westcove’s persistence, expertise, and extensive relationships — without their hard work and dedication, we would not have overcome the challenges along the way.”

– Denton Watumull, M.D., Partner at RPSC

Williamsburg Dental Partners with Cordental Group (backed by NMS Capital)

Williamsburg Dental is a multi-location dental practice delivering comprehensive general dentistry services through a team of four dentists, serving approximately 10,400 active patients, with a strong emphasis on patient experience and community relationships. The partnership provides Williamsburg Dental with additional resources and infrastructure to support continued growth, clinician recruitment, and enhanced patient access.

“Westcove’s exceptional guidance and expertise were invaluable throughout this process. Their commitment to understanding our practice and structuring a seamless transaction allowed us to focus on what we do best—providing outstanding patient care.”

– Dr. Robert Spennato, Partner, Williamsburg Dental

Active Coverage Sectors

In addition to current and past clients, Westcove is actively covering 35+ healthcare service subsectors. Our team serves as an educational resource for founder-operators, financial sponsors, and third parties across these subsectors.

Industry Participation and Recognition

Westcove Partners strengthened its industry presence and influence in 2025 through prestigious recognitions, expanded strategic partnerships, and continued investment in transformative healthcare innovations. We remain firmly committed to delivering excellence in financial advisory services while supporting initiatives that advance the healthcare and investment ecosystem.

The M&A Atlas Awards Healthcare Boutique Investment Bank of the Year

In February 2025, Westcove Partners was named Healthcare Boutique Investment Bank of the Year for 2024 at the M&A Atlas Awards | Americas, marking the second consecutive year the firm has received this honor. The recognition underscores Westcove’s growing reputation as a specialized advisor to founder-led healthcare businesses and highlights the team’s track record of delivering thoughtful, high-impact outcomes in a complex M&A environment. Building on the firm’s 2024 win, Westcove was again nominated for Healthcare Boutique Investment Bank of the Year for 2025 by the M&A Atlas Awards | USA. This continued recognition reflects Westcove’s deep sector focus, founder-centric approach, and consistent execution on complex transactions across the healthcare continuum.

Grady Campbell Top 50 Middle Market Investment Bank

In August 2025, Grady Campbell recognized Westcove as one of its Top 50 Investment Banks in the Middle Market. The firm was highlighted for its exclusive focus on healthcare services and its work with founder-owned businesses in the lower middle market. Since inception, Westcove has advised on more than 25 closed healthcare transactions totaling nearly $1.5 billion in enterprise value, reflecting meaningful growth from the $1.1 billion milestone noted a year earlier.

Firmwide Contributions

Since inception, Westcove has allocated more than $1.5 million of firm-generated funds to scholarships and underrepresented founders, supporting initiatives such as the UCLA Anderson Westcove Partners Endowment and Northeastern University’s F1RST Scholars Program, among others. These efforts complement the firm’s impact-focused investing activity and reflect a long-term commitment to expanding access to education and capital for underrepresented communities.

Northeastern University D’Amore-McKim School of Business

In 2025, Westcove continued to expand its early-career talent pipeline through summer internships and a new co-op partnership with Northeastern University D’Amore-McKim School of Business. The program provides students with hands-on experience in healthcare M&A, and in January 2025 Westcove welcomed its first Northeastern co-op interns as part of this initiative. Westcove has also reaffirmed its support for the Northeastern University D’Amore-McKim School of Business F1RST Scholars program with a pledge of $100,000 to continue for the next 5 years, underscoring our commitment to empowering historically underserved students and entrepreneurs. In January 2026, Westcove will welcome its third Northeastern co-op intern.

Westcove Partners Endowment Update

In March 2025, the Westcove Partners Endowment at UCLA Anderson announced Kelly Young (MBA ’26) as its second fellowship recipient. Established in 2022 as a $500,000 endowed fund, the Endowment supports underrepresented full-time MBA students by reducing financial barriers to graduate business education. In December 2025, Westcove awarded the fellowship for a third consecutive year, naming Kelly Young as a repeat recipient. Kelly is an active leader in the UCLA Anderson community, serving in leadership roles with the Entertainment Management Association and the Black Business Students Association.

Team Growth

In 2025, Westcove celebrated two promotions: Abe M’Bodj to Managing Director and Amr Baumy to Associate. Abe’s promotion reflects his leadership, consistent execution, and central role in originating and leading complex sell-side engagements, as well as his contributions to mentoring the team and shaping the firm’s strategic direction. Amr’s promotion recognizes his strong performance and expanding responsibilities across transaction execution, financial analysis, and client support. Together, these promotions underscore Westcove’s culture of accountability and professional development, supporting growth from three team members in January 2021 to eight by year-end 2025.

Westcove also continued investing in its team to support increasing transaction volume. Andrew Hartono joined as an Analyst in February, strengthening analytical support, and Caitlyn Hoffman joined in October as Executive Assistant and the firm’s first operations hire, enhancing internal coordination and enabling the deal team to remain focused on clients.

Internship Program

In 2025, Westcove expanded its early-career recruiting through summer internships and the launch of a Northeastern University co-op program, complementing its longstanding partnerships with UCLA Anderson and USC Marshall. The firm welcomed its first Northeastern co-op interns in January 2025, with another expected in early 2026, and will continue its academic internship program with a Summer Analyst joining in 2026.

Print Friendly, PDF & Email